Bradley J. Bolzon PhD

Insider Reports History

Entity
Individual
Location
One Sansome Street, Suite 3630, San Francisco, CA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradley J. Bolzon PhD:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Common Stock 6.8M $129M $19.00 Jun 28, 2021 By Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Common Stock 2.1M $39.9M $19.00 Jun 28, 2021 By Versant Vantage I, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 47.1K Jun 23, 2021 Direct
Black Diamond Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 15K Jun 18, 2021 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 12K Jun 9, 2022 Direct
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series A convertible preferred stock 0 Jun 28, 2021 By Versant Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 By Versant Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 By Versant Vantage I, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series C convertible preferred stock 0 Jun 28, 2021 By Versant Vantage I, L.P.

Insider Reports Filed by Bradley J. Bolzon PhD

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CRSP CRISPR Therapeutics AG Jul 19, 2021 4 -$1.26M 4 Jul 21, 2021 Director
CRSP CRISPR Therapeutics AG Jun 28, 2021 25 -$7.11M 4 Jun 30, 2021 Director
CRSP CRISPR Therapeutics AG Jun 28, 2021 14 -$4.63M 4 Jun 30, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $3M 4 Jun 30, 2021 Director, 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director, 10%+ Owner
CRSP CRISPR Therapeutics AG Jun 11, 2021 5 -$1.27M 4 Jun 15, 2021 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Feb 24, 2021 4 $15.1M 4 Jun 25, 2021 Director, 10%+ Owner